Skip to main content
. Author manuscript; available in PMC: 2024 Apr 18.
Published in final edited form as: Transplant Proc. 2023 Jan 7;55(1):56–65. doi: 10.1016/j.transproceed.2022.12.008

Table 3.

Waitlist Outcomes for Medicaid vs Privately Insured Transplant Candidates

Era 1: 2007–2010 Era 2: 2011–2014 Era 3: 2015–2018
HR (95% CI) HR (95% CI) HR (95% CI)
Kidney waitlist outcomes
Transplant 0.62 (0.60–0.64) 0.67 (0.65–0.69) 0.77 (0.74–0.80)
Death/delisting 1.18 (1.12–1.23) 1.19 (1.13–1.25) 1.11 (1.03–1.19)
Liver waitlist outcomes
Transplant 0.86 (0.83–0.90) 0.86 (0.83–0.89) 0.79 (0.77–0.82)
Death/delisting 1.27 (1.20–1.35) 1.23 (1.17–1.30) 1.19 (1.12–1.27)

Results from multivariable competing risks regression models adjusted for patient characteristics. HR: Hazard Ratio, CI: Confidence Interval